What APOE4 Carriers Can Do Today to Support Gut-Mediated Inflammation Resolution

Part 2 of 2: The Practical Guide

In Part 1, we explored why APOE4 carriers struggle to produce specialized pro-resolving mediators (SPMs)—the molecules that actively shut down inflammation. The gut microbiome emerged as a potential “microbial bypass,” with certain bacteria capable of converting omega-3s into SPM precursors even when your own enzymes are dysfunctional.

But what can you actually do with this information today?

This article translates the science into actionable strategies—grounded in evidence, appropriately cautious about limitations, and focused on what’s available now rather than what’s still in research pipelines.